Medicare demo emerges as coverage option for Alzheimer’s drug ...Middle East

Roll Call - News
Medicare demo emerges as coverage option for Alzheimer’s drug
The decision on how to cover an expensive and controversial new Alzheimer’s drug could be settled by letting Medicare run its own trial to study payment and treatment implications. Aduhelm, from drugmakers Biogen and Eisai, won accelerated approval from the Food and Drug Administration earlier this month despite objections from the agency’s advisory committee. While clinical trials […] The post Medicare demo emerges as coverage option for Alzheimer’s drug appeared first on Roll Call.

Hence then, the article about medicare demo emerges as coverage option for alzheimer s drug was published today ( ) and is available on Roll Call ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medicare demo emerges as coverage option for Alzheimer’s drug )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News